Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

UBT251

Phase I Drug-Drug Interaction Study of UBT251 Injection in Participants With Overweight or Obesity

The United Bio-Technology (Hengqin) Co · Phase 1 · Recruiting · Enrollment 48

NCT07785934

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
UBT251n/rn/rn/rn/r

Not shown

  • UBT251: endpoint not reported